Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mosekilde

Showing results (71-80 of 394) with videos related to

Pageof 40
Sort By:
Ugeskrift for Laeger|October 12, 1992
[Research on aging: biological perspectives]A Viidik, L Mosekilde, A Quirinia
Acta Endocrinologica|May 1, 1981
Iliac crest bone mass and remodelling in acromegalyJ Halse, F Melsen, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1981
Effects of thyroid hormone(s) on mean wall thickness of trabecular bone packetsJ Kragstrup, F Melsen, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1983
Thickness of bone formed at remodeling sites in normal human iliac trabecular bone: variations with age and sexJ Kragstrup, F Melsen, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2010
Risk of fractures associated with treatment for benign prostate hyperplasia in menP Vestergaard, L Rejnmark, L Mosekilde
Bone|October 8, 1999
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approachE Hauge, L Mosekilde, F Melsen
Pharmacoeconomics|July 24, 2001
Hip fracture prevention: cost-effective strategiesP Vestergaard, L Rejnmark, L Mosekilde
Journal of Internal Medicine|June 23, 2006
Fracture risk associated with the use of morphine and opiatesP Vestergaard, L Rejnmark, L Mosekilde
European Journal of Clinical Investigation|October 1, 1986
Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled studyC Hasling, P Charles, L Mosekilde
Journal of Internal Medicine|December 13, 2005
Fracture risk in patients treated with loop diureticsL Rejnmark, P Vestergaard, L Mosekilde
Pageof 40

Showing results (71-80 of 394) with videos related to

Sort By:
Pageof 40
Ugeskrift for Laeger|October 12, 1992
[Research on aging: biological perspectives]A Viidik, L Mosekilde, A Quirinia
Acta Endocrinologica|May 1, 1981
Iliac crest bone mass and remodelling in acromegalyJ Halse, F Melsen, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1981
Effects of thyroid hormone(s) on mean wall thickness of trabecular bone packetsJ Kragstrup, F Melsen, L Mosekilde
Metabolic Bone Disease & Related Research|January 1, 1983
Thickness of bone formed at remodeling sites in normal human iliac trabecular bone: variations with age and sexJ Kragstrup, F Melsen, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2010
Risk of fractures associated with treatment for benign prostate hyperplasia in menP Vestergaard, L Rejnmark, L Mosekilde
Bone|October 8, 1999
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approachE Hauge, L Mosekilde, F Melsen
Pharmacoeconomics|July 24, 2001
Hip fracture prevention: cost-effective strategiesP Vestergaard, L Rejnmark, L Mosekilde
Journal of Internal Medicine|June 23, 2006
Fracture risk associated with the use of morphine and opiatesP Vestergaard, L Rejnmark, L Mosekilde
European Journal of Clinical Investigation|October 1, 1986
Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled studyC Hasling, P Charles, L Mosekilde
Journal of Internal Medicine|December 13, 2005
Fracture risk in patients treated with loop diureticsL Rejnmark, P Vestergaard, L Mosekilde
Pageof 40